168 results
Page 3 of 9
8-K
2ft1euto
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-1.1
sz56yg8j1f8de6sw 7pg
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
s6jry71l2
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
ij7b4856y7 xeip
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
q4rta4 54
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
3ehcu hu1syx3uvq
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
5ixck3 ye01
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
banfp4r 0wv8kf
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
yx2i7
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
p14ooj
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.1
er5fdwx 4i5k
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am
8-K
EX-99.2
ehnmk6et
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
9awjoxl48riu
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
ban2cfy3i4gbnll
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am